Cite

HARVARD Citation

    Hauschild, A. et al. (2017). Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab. European journal of cancer. pp. 84-87. [Online]. 
  
Back to record